City
Epaper

2 arthritis drugs show different results in Covid-19 trials

By IANS | Updated: April 28, 2020 22:25 IST

With different approaches to treating Covid-19 patients being tried, varying results of two different arthritis drug trials on patients have further complicated the search for a cure.

Open in App
inhibitor tocilizumab rapidly reduced fever and improved oxygenation in severe patients, allowing for successful hospital discharge.

gb/arm

( With inputs from IANS )

Open in App

Related Stories

InternationalJustice Suryakant BICC opens new avenues for cooperation, Justice Kaul terms it a unique transnational model

InternationalAfghanistan, Pakistan set for third and "final round" of talks after earlier attempts fail

InternationalLaw Minister Arjun Meghwal hails Bahrain's arbitration initiative, calls BICC a landmark in strengthening India-Bahrain commercial ties

InternationalUS: Supreme Court poses tough questions as arguments begin over Trump's global tariffs

NationalOdisha to emerge as gateway of eastern India in maritime trade sector: CM Majhi

Health Realted Stories

HealthScientists find E. Coli spreads as fast as swine flu: Study

HealthUpcoming super speciality hospital to boost Tripura’s healthcare infrastructure: CM Saha

Health2025 dengue death toll in Bangladesh crosses 300 with 10 new fatalities

HealthScience, R&D, advanced materials key pillars for Viksit Bharat 2047: CSIR

HealthDLC Campaign 4.0: Over 55 lakh Digital Life Certificates generated in first 4 days